All three types of CD4+ T-cells and all dnT-cell types exhibited marked scores for ATLL signatures, but CD8+ T-cell types and NKT scored low, suggesting tumor malignancy of ATLL is more associated with CD4+ and dnT-cells than CD8+ and NKT cells. The gene discussed is CD8A; the disease is neoplasm.